AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea · Delayed Price · Currency is KRW 59,300
-4,800 (-7.49%)
At close: Apr 30, 2026
AprilBio Market Cap
AprilBio has a market cap or net worth of 1.38 trillion as of April 30, 2026. Its market cap has increased by 367.42% in one year.
Market Cap
1.38T
Enterprise Value
1.29T
Revenue
2.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
59,300.00
Market Cap Chart
Since July 28, 2022, AprilBio's market cap has increased from 229.75B to 1.38T, an increase of 502.50%. That is a compound annual growth rate of 61.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 1.50T | 17.43% |
| Dec 30, 2025 | 1.27T | 250.56% |
| Dec 30, 2024 | 363.46B | -0.02% |
| Dec 28, 2023 | 363.53B | 96.13% |
| Dec 29, 2022 | 185.35B | -19.33% |
| Jul 28, 2022 | 229.75B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aimed Bio | 3.16T |
| Rznomics | 2.60T |
| Qurient | 1.60T |
| JS Link | 1.46T |
| ROKIT Healthcare | 1.29T |
| Curocell | 977.37B |
| Inventage Lab | 827.18B |
| IMBiologics | 793.48B |